Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
510 Kardiac Devices
Mableton, Georgia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
510 Kardiac Devices developed the Lim Transseptal System, a transseptal access device intended to improve efficacy and safety of left-sided structural heart procedures; it pursued FDA 510(k) clearance before being acquired by Keystone Heart, a Venus Medtech company.[1][3][7]
- Therapeutic areas
- Cardiovascular
- Modalities
- Device
- Industry
- Surgical Medical Devices
02
Partnerships
Keystone HeartVenus Medtech
Beyond the preview
Go deeper on 510 Kardiac Devices.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 510 Kardiac Devices.